Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I

The brassinosteroid (BR) signaling pathway includes two receptor-like kinases (BRI1 and BAK1), a plasma membrane-associated… Expand

A longitudinal clinical trial involving 103 subjects was undertaken to assess the impact of oral implant therapy on the… Expand

UNLABELLED Patient-based assessment of oral health outcomes is of growing interest. Measurement of change following clinical… Expand

STATEMENT OF PROBLEM Outcomes of oral implant therapy have been described primarily in terms of implant survival rates and the… Expand

Cyclic di-GMP (c-di-GMP) is the specific nucleotide regulator of beta-1,4-glucan (cellulose) synthase in Acetobacter xylinum. The… Expand

Carbohydrate-deficient-glycoprotein syndrome type 1 (CDG1; also known as "Jaeken syndrome") is an autosomal recessive disorder… Expand

Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1; McKusick No. 212065) is an autosomal recessively inherited disease… Expand

Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken syndrome) is the prototype of a class of genetic multisystem… Expand

We have cloned the human homologue of SEC53 or yeast phosphomannomutase (HGMW-approved symbol PMM1) from a liver cDNA library… Expand

Carbohydrate-deficient glycoprotein syndrome type I is a multisystem disease with early severe nervous system involvement. The… Expand